id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2028482,33e2dd2d-cbda-4607-b4ce-e9d8bfb042f3,Q3,"CHATMAN, LLC",400678024,LIVINGSTON GROUP FOR RUSH UNIVERSITY MEDICAL CENTER,2017,third_quarter,PHA,Support continuation of Pharmacy 340B program in HRSA.  Provide comments to FDA proposed rule change.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2017-10-17T22:34:07.140000-04:00